My Personal CFO LLC’s Medtronic MDT Stock Holding History

My Personal CFO LLC’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-272	Closed	-$21.1K	–	519
2022 Q4	$21.1K	Buy	+272	New	+$22K	0.02%	199

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

My Personal CFO LLC's MDT Position: Q1 2023 in Review

My Personal CFO LLC sold out of Medtronic (MDT) in Q1 2023, closing a stake of 272 shares — an estimated $21.1K sold.

My Personal CFO LLC first reported a position in MDT in Q4 2022 and held it in 1 quarter. The position peaked at $21.1K in Q4 2022. 1,990 funds tracked by Wall St. Rank hold MDT as of Q1 2023.

My Personal CFO LLC reported no remaining Medtronic position as of Q1 2023 after selling out during the quarter.
My Personal CFO LLC sold 272 Medtronic shares in Q1 2023, an estimated $21.1K.
My Personal CFO LLC first reported a position in Medtronic in Q4 2022 and held it in 1 quarter.
My Personal CFO LLC's Medtronic position peaked at $21.1K in Q4 2022.
1,990 funds tracked by Wall St. Rank held Medtronic as of Q1 2023.

Based on My Personal CFO LLC's 13F filing for Q1 2023, filed 21 Apr 2023.